Quantcast

Latest Lupus Stories

2011-01-27 14:24:50

Activation of interferon signaling pathway may cause premature plaque build-up Researchers in China have demonstrated interferon-alpha (IFN-a) is associated with increased risk of atherosclerosis in patients with systemic lupus erythematosus (SLE). For the first time, IFN-a priming was shown to promote lipid uptake and foam cell formation"”a crucial step in plaque build-up. This activation of the IFN signaling pathway may be linked to the premature atherosclerosis risk in SLE. Full...

2010-12-31 12:20:16

(Ivanhoe Newswire) "“ A new study provides insight into the underlying pathology associated with the autoimmune disease, systemic lupus erythematosus (SLE). The research shows an unexpected role for a key type of immune cell could provide a potential new therapeutic strategy for SLE and, possibly, other autoimmune diseases. SLE is a chronic systemic disease that can affect many regions of the body and, as a result, presents with diverse clinical symptoms. As is characteristic of other...

2010-12-23 13:30:00

Lupus Foundation of America Highlights the Year's Top Ten Achievements WASHINGTON, Dec. 23, 2010 /PRNewswire-USNewswire/ -- Events of 2010 represented the beginning of the long anticipated transition to a new era in which the 1.5 million Americans and the more than five million individuals worldwide living with the autoimmune disease lupus can look forward to an improved quality of life. Potential new treatments for lupus passed several milestones on the road toward approval, public and...

2010-12-14 15:15:00

HAYWARD, Calif., Dec. 14, 2010 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with abnormal auto-immune responses and inflammation, has selected the Merck BioManufacturing Network in the UK, to manufacture the large scale GMP clinical and pre-commercial supplies of A-623, an investigational novel peptibody in development for a number of autoimmune diseases. "Establishing a rapid and high...

2010-12-09 16:00:00

Event Raises Crucial Funds for Lupus Research for 5 Million People Worldwide Living with Lupus NEW YORK, Dec. 9, 2010 /PRNewswire-USNewswire/ -- The Alliance for Lupus Research (ALR) honored Rupert Murdoch, News Corporation Chairman and CEO, at its 2010 One Love One Cause Gala event. Murdoch was recognized Wednesday, December 8, 2010 at the Mandarin Oriental Hotel with a 6:30pm reception and 8:30pm dinner and award presentation in honor of his support of the ALR. In attendance to honor...

2010-11-29 11:16:00

WASHINGTON, Nov. 29, 2010 /PRNewswire/ -- The Lupus Foundation of America-DC/MD/VA Chapter will celebrate its newly expanded services to more than 80,000 lupus patients throughout Washington, Maryland and Virginia--after tripling its members in just three years. Emceed by WUSA-TV Channel 9 News Anchor Anita Brikman, the Chapter's Annual Gala Luncheon and Auction on Saturday, Dec. 11 from 11:30 a.m. - 3:00 p.m. at the Old Ebbitt Grill will include an exceptional silent auction. The event...

2010-11-22 05:30:00

DENVER, Nov. 22, 2010 /PRNewswire/ -- On November 20 at the American Society of Nephrology 43rd Annual Meeting, Columbia University Assistant Professor of Clinical Medicine Andrew Bomback, MD, presented results from a patient case series assessing the potential therapeutic value of H.P. Acthar® Gel (repository corticotropin injection) as a treatment for patients with nephrotic syndrome, a kidney disorder characterized by excessive loss of urinary protein. Initial data...

2010-11-16 17:05:00

NEW YORK, Nov. 16, 2010 /PRNewswire-USNewswire/ -- The Lupus Research Institute (LRI) and its National Coalition of state and local lupus organizations are pleased with the U.S. Food and Drug Administration (FDA) Advisory Committee's vote to recommend approval of Benlysta(®) for active systemic lupus erythematosus (SLE), offering patients new found hope for the first approved treatment option in more than 50 years. The U.S. FDA Arthritis Advisory Committee voted 13 to 2...

2010-11-16 16:29:00

WASHINGTON, Nov. 16, 2010 /PRNewswire-USNewswire/ -- Today the U.S. Food and Drug Administration (FDA) Arthritis Advisory Committee voted overwhelmingly (13 to 2) to recommend BENLYSTA® for approval as a treatment for the autoimmune disease lupus. If FDA approved, BENLYSTA would become the first new treatment for lupus in 52 years. While today's vote is a positive step, the FDA still must make a final decision to approve BENLYSTA in the coming weeks. Sandra C. Raymond,...

2010-11-09 20:56:43

Mary Kirkland Center for Lupus Care at Hospital for Special Surgery brings together patient care, education and research The benefits of collaborative, multidisciplinary care of patients with complex autoimmune diseases like lupus and multiple sclerosis are just beginning to be appreciated by physicians. Hospital for Special Surgery in New York will present evidence of the advantages of such a specialized disease center dedicated to comprehensive lupus care at the 74th Annual Meeting of the...


Latest Lupus Reference Libraries

10_727908da8421f900a92d7a25ed6718ea2
2004-10-19 04:45:44

Lupus (the wolf) Constellation -- Lupus belongs to the constellations of the Southern Hemisphere roughly between DECL=-30 degrees and DECL=-55 degrees and RA=14h 20m and RA=16h 15m, respectively. It is located between Centaurus on the western and Scorpius and Norma on the eastern boundary. In the north Lupus borders on Libra, to the south it tops Circinus. As a part of the Milky Way stretches through Lupus it is an interesting part of the sky for simple stargazing with binoculars....

More Articles (1 articles) »
Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.